Abstract
Normocalcaemic hyperparathyroidism is a common biochemical finding, usually identified during an assessment of bone or renal health. Hypercalcaemia must be considered by calculation of adjusted calcium, and a careful history taken to assess dietary calcium intake and for the possibility of a malabsorption syndrome. 25OHD should be measured and replaced if indicated. The management plan for the patient is influenced by the context in which calcium and PTH were measured. In this brief review we describe the assessment of a patient with normocalcaemic hyperparathyroidism. This article is protected by copyright. All rights reserved.
Original language | English |
---|---|
Journal | Clinical Endocrinology |
Early online date | 21 Mar 2016 |
DOIs | |
Publication status | E-pub ahead of print - 21 Mar 2016 |